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Overexpression and inhibitor studies have suggested that the c-Myc target gene for ornithine decarboxylase
(ODC), the enzyme which converts ornithine to putrescine, plays an important role in diverse biological pro-
cesses, including cell growth, differentiation, transformation, and apoptosis. To explore the physiological func-
tion of ODC in mammalian development, we generated mice harboring a disrupted ODC gene. ODC-heterozy-
gous mice were viable, normal, and fertile. Although zygotic ODC is expressed throughout the embryo prior to
implantation, loss of ODC did not block normal development to the blastocyst stage. Embryonic day E3.5 ODC-
deficient embryos were capable of uterine implantation and induced maternal decidualization yet failed to
develop substantially thereafter. Surprisingly, analysis of ODC-deficient blastocysts suggests that loss of ODC
does not affect cell growth per se but rather is required for survival of the pluripotent cells of the inner cell
mass. Therefore, ODC plays an essential role in murine development, and proper homeostasis of polyamine
pools appears to be required for cell survival prior to gastrulation.
Overexpression of the c-Myc, N-Myc, or L-Myc members of
the Myc oncogene family is a common event in human tumors.
This selection likely reflects Myc’s ability to provide continuous
proliferative and angiogenic signals under growth-limiting con-
ditions, such as those that occur in the tumor microenviron-
ment (38). However, Myc’s propensity to induce continuous
proliferation also blocks terminal differentiation (11) and trig-
gers the apoptotic program (2). c-Myc is a basic helix-loop-
helix leucine zipper protein that exhibits sequence-specific
DNA binding to CACGTG or CACATG elements when
dimerized with its obligate basic helix-loop-helix leucine zipper
partner Max (8). Despite Myc’s well-defined function as a
transcriptional transactivator, the numbers of its ascribed tar-
gets that have been proven to be direct are relatively few, but
they do include ornithine decarboxylase (ODC) (6), -prothy-
mosin (15), eIF-4E (44), carbamoyl-phosphate synthase-as-
partate carbamoyltransferase-dihydroorotase (cad) (28), a
DEAD box-related gene (MrDb) (20), the ubiquitin E2 ligase
Cul1 (32), and ECA39 (7). A compelling example of a target
gene that contributes to c-Myc’s biological effects is ODC (34,
35), which is activated by growth factors and by c-Myc through
two conserved CACGTG sites present in the first intron of
vertebrate ODC genes (6). ODC is the key regulator of the
polyamine biosynthetic pathway and decarboxylates L-orni-
thine to form putrescine (50). ODC expression is highly regu-
lated by changes in its transcription, translation, and RNA and
protein half-life (40). Furthermore, ODC enzyme activity is
tightly controlled and shows biphasic induction during late G1
and at G2/M (5). Inhibition of ODC by difluoromethylorni-
thine (DFMO) compromises cell growth and transformation
(3) and induces cell cycle arrest in G1 (35, 43). ODC inhibition
results in marked reductions in the intracellular levels of the
polyamines putrescine, spermidine, and spermine, which ap-
pear essential for fundamental processes such as stabilization
of chromatin and cytoskeletal structure (4), translation (37),
transcription (10), semiconservative DNA replication (42), and
the protection of cells from DNA damage (25). Chronic re-
ductions in polyamine levels have also been reported to lead to
apoptosis, especially following exposure to oxidative stress (14).
Paradoxically, ODC overexpression, which upregulates pu-
trescine levels, can also trigger the apoptotic program (34).
Overall, these findings strongly support the concept that
proper homeostasis of polyamine pools is a critical determi-
nant of cell fate.
In eukaryotes, loss-of-function mutations in ODC have been
created in Saccharomyces cerevisiae and Leishmania donovani,
and a naturally occurring ODC mutant has been identified for
the nematode Caenorhabditis elegans. Loss of ODC in haploid
yeast results in a cessation of growth (45), whereas deletion of
ODC in L. donovani (23) and C. elegans (26) is lethal, unless
these animals are supplied with exogenous putrescine or poly-
amines in their diets. However, the cause of the lethality of
ODC deficiency in these lower organisms is not resolved, and
relatively little is known about the role of ODC during verte-
brate embryogenesis. To address this issue directly, we exam-
ined the biological role of ODC in the mouse by gene targeting,
and we demonstrate a critical in vivo role for ODC in promot-
ing cell survival prior to gastrulation.
MATERIALS AND METHODS
Construction of the ODC targeting vector. Genomic clones of the murine ODC
gene were isolated from a 129/SVE mouse genomic library in EMBL3 using a
full-length murine ODC cDNA probe (kindly provided by Daniel Nathans).
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Positive clones were restriction mapped, subcloned into pBluescript SK(), and
sequenced. Standard recombinant techniques were used to design the targeting
vector schematically shown in Fig. 1A. A 304-bp SalI-SstI fragment that included
most of exon 2 and all of exon 3, including the translation start site of the ODC
gene, was replaced by an internal ribosome entry site-linked LacZ-neomycin
cassette (31), which allowed the positive selection of recombinant clones. A
herpes simplex virus thymidine kinase cassette mediating negative selection was
inserted in the 3 end of the construct at the HindIII site within ODC (Fig. 1A).
Targeting of ES cells and generation of ODC-deficient mice. Linearized vector
DNA was introduced by electroporation into W9.5 embryonic stem (ES) cells
cultured as described previously (36). Following selection with G418 (250 g/ml)
and 1-(2’-deoxy-2’-fluoro--D-arabinofuranosyl)-5-iodouracil (FIAU) (1 M),
eight correctly targeted homologous recombinants were identified by PCR and
Southern blotting (see below). To generate chimeric mice, C57BL/6J blastocysts
injected with two independent ODC/ ES clones were implanted into pseudo-
pregnant foster mothers. Several chimeric males, identified by their agouti coat
color, gave germ line transmission, and their offspring were screened for the
presence of the disrupted ODC gene. All animal experiments performed fully
complied with federal and institutional guidelines.
PCR assays. Genotyping of mice and embryos older than E8.5 was performed
on tail DNA and visceral yolk sac DNA, respectively, lysed at 55°C in 400 l of
lysis buffer (500 mM KCl, 100 mM Tris-HCl [pH 8.3], 0.1 mg of gelatin/ml, 1%
NP-40, 1% Tween 20, 500 g of proteinase K/ml) for 3 h. The proteinase K was
inactivated by boiling for 10 min, and 3 l from each sample was used for
standard PCR using the Taq PCR Core kit (Qiagen). For embryos younger than
E8.5, and for blastocyst outgrowths, different buffers (described in reference 51)
were used. In all cases, a mixture of three PCR primers was used to detect
wild-type and mutant alleles: P1 (5-CGAGGTCCGCAACATAGAACG-3), P2
(5-CTCTGTAAGTACGGGAAGCCC-3), and NEO (5-CCCACACCTCCCC
CTGAACC-3), which amplified 270-bp (wild-type) and 470-bp (knockout) frag-
ments. The PCR cycle profile was as follows: 1 cycle of 94°C for 4 min, followed
by 34 cycles (standard) or 39 cycles (blastocysts) of 94°C for 1 min, 64°C for
1 min, and 72°C for 1 min, and finally 1 cycle of 72°C for 6 min. PCR products
were analyzed by standard agarose gel electrophoresis.
In vitro culture of blastocyst outgrowths. Natural matings between male and
female ODC/ mice were used to obtain embryos of all genotypes (wild type,
ODC/, and ODC/). Embryos were staged according to the detection of
vaginal plugs resulting from the crosses (noon of day 1 of plugging equals E0.5).
Blastocysts at E3.5 were flushed from the uterine horns, extensively washed in
phosphate-buffered saline (PBS), and cultured individually in ES cell medium
lacking leukemia inhibitory factor on gelatin-coated 96-well plates for 5 to 6 days.
Morphology of the outgrowths was assessed at specific intervals, photographs
were taken with an inverted microscope (Olympus), and the genotype of the
blastocyst cultures was determined by PCR.
Whole-mount LacZ staining. Free-floating blastocysts were fixed in 0.2% (vol/
vol) glutaraldehyde and 1% (vol/vol) formaldehyde in PBS for 10 min at room
temperature (RT) and washed extensively. LacZ activity was assessed by incu-
bation of the embryos at 37°C in the histochemical reaction mixture [1 mg of
4-chloro-5-bromo-3-indolyl--galactosidase (X-Gal)/ml, 4 mM K4Fe(CN)6 
3H2O, 4 mM K3Fe(CN)6, and 2 mM MgCl2 in PBS] for 20 h in a humidified
chamber.
TUNEL assays. E3.5 to E4.0 embryos resulting from heterozygous intercrosses
were collected, washed in PBS, and fixed in freshly prepared 4% paraformalde-
hyde in PBS for 15 min at RT. After permeabilization in PBS containing 0.1%
(vol/vol) Na citrate–0.1% (vol/vol) Triton X-100 for 10 min at RT, they were
washed twice in PBS and tested for evidence of apoptosis by TUNEL (terminal
deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling), accord-
ing to the manufacturer’s instructions (in situ cell death detection kit, fluores-
cein; Roche). At the end of the assay, blastocysts were washed, individually
transferred to a drop of PBS on a depression slide, and examined by confocal
laser scanning microscopy.
Immunofluorescence. The first steps of the procedure were the same as for the
TUNEL assays described above. Following permeabilization and washing, the
embryos were stained overnight at 4°C with an antibody specific to phosphohi-
stone H3 at Ser10 (1:200 dilution; Upstate Biotechnology) in a drop of PBS
containing 0.7% bovine serum albumin and 10% goat serum, under mineral oil.
After three washes in PBS for 5 min, anti-phosphohistone H3 antibody binding
was detected with Cy3-conjugated secondary antibody to rabbit immunoglobulin
G (1:200; Jackson Laboratories). Embryos were then washed in PBS and imme-
diately analyzed for immunofluorescence by confocal microscopy.
For ODC whole-mount immunofluorescence, the blastocysts were first incu-
bated in blocking solution (1% goat serum in PBS) for 20 min and then stained
with anti-ODC antibody (B250-1; Accurate Chemical & Scientific Corp.) at a
1:100 dilution in blocking solution for 2 h at RT. After three washes in PBS (10
min each), they were incubated with the secondary antibody Alexa-488 anti-
rabbit immunoglobulin G (Molecular Probes) in blocking solution for 1 h at RT.
The embryos were then treated for 30 min at RT with RNase A and stained with
propidium iodide for 5 min. They were finally washed in PBS and mounted on
slides for analysis by confocal microscopy.
Histological analysis. Deciduae at E5.5 were isolated, fixed in 10% buffered
formalin overnight at 4°C, processed, and embedded in paraffin using standard
procedures. Four-micrometer-thick sections were prepared and stained with
hematoxylin and eosin. Coverslips were removed from sections to be microdis-
sected by immersion in xylene, and the sections were air dried. Embryonic tissue
was microdissected using a PALM laser microscope system (PALM Microlaser
Technologies, Bernied, Germany). Microdissected tissue was catapulted into the
caps of microcentrifuge tubes, and the DNA was subsequently extracted and
subjected to PCR amplification.
Putrescine rescue experiments. Intact uteri were removed at E6.5 and E7.5
from heterozygous pregnant females which had been administered putrescine
(Sigma) at a concentration of 0.1 mM in their drinking water from the day on
which a vaginal plug was detected. Water was changed daily to ensure putrescine
stability and effectiveness. Embryos were dissected from the decidua and geno-
typed as described above.
RESULTS
Gene targeting of murine ODC results in embryonic lethal-
ity. We constructed a targeting vector in which ODC sequences
encompassing most of ODC exon 2 and all of exon 3, including
the ATG initiation codon, were deleted by replacement with
an internal ribosome entry site-LacZ-Neo (-geo) selection
cassette. The herpes simplex virus thymidine kinase gene was
used as a negative selection marker (Fig. 1A). The choice of a
promoterless targeting strategy was based on the observations
made by Northern blotting that the ODC gene is actively tran-
scribed in ES cells (data not shown). The insertion of the -geo
expression cassette deletes the first 35 amino acids of ODC.
This targeting construct was introduced into W9.5 ES cells by
electroporation, and cells that had undergone homologous re-
combination were enriched by selection with G418 and FIAU
and identified by PCR and Southern blotting (Fig. 1B). Eight
independent correctly targeted clones were identified, and two
having a normal karyotype were microinjected into C57BL/6
blastocysts and transplanted into pseudopregnant females.
High- and medium-chimeric mice were obtained and subse-
quently transmitted the mutated ODC allele to their progeny.
The validity of the ODC mutation was confirmed by perform-
ing ODC enzyme assays using whole-cell extracts isolated from
wild-type and heterozygous (ODC/)-derived MEFs. ODC
enzyme activity was reduced by half in MEFs prepared from
ODC/ mice compared to the activity in those derived from
wild-type littermates, clearly showing a dosage effect (data not
shown). Male and female ODC/ mice appeared phenotypi-
cally normal, were fertile, and were indistinguishable in size or
growth from their wild-type littermates. However, genotyping
the litters of mice arising from ODC/ intercrosses failed to
show any homozygous null ODC mice, indicating a prenatal
lethality (Fig. 1C), although numbers of wild-type and ODC/
mice were as expected.
To precisely pinpoint the time of embryonic death, we dis-
sected embryos from heterozygous intercrosses at different
days of gestation from E6.5 to E12.5 and genotyped them by
PCR. As shown in Table 1, of the 233 deciduae tested, 178
contained morphologically normal fetuses, of which 118 were
ODC/ and 60 were wild type. No ODC/ embryos were
detected at these embryonic stages. In accord with this finding,
6550 PENDEVILLE ET AL. MOL. CELL. BIOL.
embryos were not found in about 25% of the deciduae at E6.5,
and attempts to genotype the residual tissues from these empty
implantation sites were not successful. These data indicate that
ODC-deficient embryos cannot survive to gastrulation.
To assess at what stage ODC-deficient embryos died, more
timed matings were initiated and E5.5 deciduae obtained from
ODC/ intercrosses were fixed, embedded in paraffin, sec-
tioned, and stained with hematoxylin and eosin. Histological
sections revealed obvious abnormalities that distinguished nor-
mal from mutant conceptuses following implantation (Fig. 2).
All wild-type and ODC/ embryos showed normal growth
patterns, with the typical structure of early egg cylinders. By
contrast, at this stage of development, almost one-quarter of
decidual swellings were virtually empty, with decreased num-
bers of cells and small and poorly organized embryos (Fig. 2).
Embryos having these abnormalities in organization and cel-
lular morphology were confirmed to be ODC/ by genotyping
residual tissue isolated by laser microdissection. Overall, the
data suggested that ODC/ embryos were able to implant but
quickly expired thereafter.
Exogenous sources of putrescine can rescue developmental
defects in ODC-deficient C. elegans and L. donovani (23, 26).
Furthermore, putrescine supplementation in drinking water
effectively blocks the inhibitory effects of DFMO on tumor
formation in a mouse model of skin tumors (39). We therefore





Neonate 453 951 0 NAb
E12.5 4 8 0 3c
E10.5 8 21 0 10c
E9.5 6 15 0 8c
E8.5 6 11 0 5c
E7.5 12 20 0 10d
E6.5 24 43 0 19d
a The ODC genotype of embryos was determined by PCR as described in
Materials and Methods.
b NA, not applicable.
c Resorptions.
d Residues of embryonic material.
FIG. 1. (A) Targeting strategy of the ODC genomic locus. Schematics of the wild-type locus (top), targeting vector (middle), and recombined
locus (bottom) are shown. Exons are indicated by hatched boxes, and the arrows correspond to the three primers used for PCR genotyping.
Abbreviations: St, StuI; H, HindIII; Sc, ScaI; Sl, SalI; Ss, SstI. (B) Southern blot analysis of genomic DNA isolated from ES cell clones. Digestion
of the targeted ODC locus with ScaI and hybridization to a 3 external probe show a 2.8- and an 8.3-kb band specific to the wild-type and targeted
alleles, respectively, confirming homologous recombination. (C) Transmission of the ODC mutant allele to the progeny was determined by PCR
amplification of tail DNAs using the primers described in Materials and Methods. PCR products were resolved on a 2% agarose gel in Tris-
acetate-EDTA buffer. WT and Wt, wild type; mut, mutant; HSV-TK, herpes simplex virus thymidine kinase; IRES, internal ribosome entry site.
VOL. 21, 2001 ODC IS ESSENTIAL FOR DEVELOPMENT AT IMPLANTATION 6551
addressed whether providing similar levels of putrescine in the
drinking water of pregnant female mice could extend the de-
velopment of ODC-deficient embryos. Although 0.5 to 1 mM
putrescine in the drinking water was nontoxic to adult female
mice, these doses of putrescine totally compromised pregnancy
and this was associated with a marked necrosis of the uterus
(data not shown). Presumably, this is due to high levels of
diamine oxidase that are present in the placenta and which
oxidize putrescine to produce hydrogen peroxide (9). Decreas-
ing doses of putrescine to 0.1 mM in the drinking water al-
lowed mice to carry litters to term. Plugged heterozygous mice
were therefore treated daily with this dose of putrescine from
day 1 of pregnancy, and at various intervals of gestation, litters
were harvested, examined morphologically, and genotyped. Al-
though we failed to detect ODC-deficient embryos at day E7.5
and beyond (n  41), ODC-deficient embryos were detected at
E6.5 by PCR genotyping that appeared phenotypically normal
in terms of development and size (data not shown). However,
the expected Mendelian ratio was not obtained, as only two
E6.5 ODC-null embryos were observed out of a total of 68,
indicating that this dose of putrescine can only partially rescue
the deleterious effects of ODC deficiency.
Zygotic ODC is dispensable prior to implantation. To fur-
ther address the developmental stage at which the defect of
ODC-null embryos was manifest, we analyzed blastocysts
(E3.5) generated from ODC/ intercrosses after flushing
these from the uteral lumen. PCR genotyping of the blastocysts
revealed that ODC/ blastocysts were present at nearly an
expected Mendelian ratio (21% [Fig. 3A]) and that they ap-
peared morphologically identical to their wild-type and het-
erozygous counterparts, with a distinct inner cell mass (ICM)
and an outer layer of trophoectoderm (TE) cells (Fig. 3B).
ODC expression has been detected by reverse transcription-
PCR in two-cell embryos (13), and yet it is unclear whether
ODC is zygotic or maternal in origin. Analysis of ODC and
-galactosidase expression in heterozygous embryos by immu-
nohistochemistry at later stages of development (E10.5 to
E12.5) confirmed coincident expression of the -galactosidase
allele and the remaining ODC wild-type allele (data not shown).
We therefore determined the pattern of zygotic ODC expres-
sion in E3.5 blastocysts. In agreement with ODC expression in
ES cells, analysis of -galactosidase activity demonstrated that
the LacZ-Neo-marked ODC allele was strongly expressed in
the ICM and yet was also detected in the TE (Fig. 3C). -Ga-
lactosidase expression can be maternally inherited. However,
-galactosidase staining was also evident in embryos resulting
from crosses between ODC/ males and wild-type females,
proving that the expression detected is zygotic. Immunostain-
ing with an ODC-specific antibody confirmed that ODC was
expressed in both the ICM and TE of wild-type blastocysts
(Fig. 3D). Reduced staining of ODC protein was evident in
ODC/ blastocysts (data not shown), and we presume that
some maternally derived ODC protein persists to this stage.
Thus, reductions in ODC do not impair development prior to
FIG. 2. Histological sections of wild-type (Wt) and ODC/ mutant embryos in utero. (A) Transverse section through the decidua of a normal
embryo at early egg cylinder stage (E5.5). Note the appearance of the proamniotic cavity and the clearly differentiated embryonic and extraem-
bryonic ectoderms. (B) Transverse section through a decidua of a degenerating E5.5 ODC/ embryo (arrow). No discernible structure can be
distinguished. pa, proamniotic cavity; ee, embryonic ectoderm; epc, ectoplacental cone; eee, extraembryonic ectoderm; ve, visceral endoderm.
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implantation, and the lethality of ODC-deficient embryos in-
deed occurs after E3.5.
ODC is required for the expansion of the ICM in vitro. To
address whether the abortive development of ODC-deficient
embryos was due to some generalized defect in cell growth, or
to lineage-specific defects, blastocysts isolated at E3.5 were
individually cultured in vitro on gelatin-coated plates for a
period of 5 days and then genotyped. During the early phases
of these cultures, most blastocysts obtained from three sepa-
rate litters (8 wild-type, 12 heterozygous, and 5 null, as geno-
typed after 3 days in culture) attached to the substratum,
hatched from the zona pellucida, and started to expand their
ICMs and to form outgrowths having the classical appearance
of migrating trophoblastic cells (Fig. 4). However, by 18 h, the
ICMs of the five ODC-null blastocysts stopped proliferating,
and they degenerated soon thereafter (Fig. 4). This phenotype
became fully manifest over the next 2 days, and only ODC-
deficient trophoblastic giant cells persisted in long-term cul-
ture (Fig. 4). Two embryos of unknown genotype were able to
attach but quickly collapsed and regressed inside the zona
pellucida, suggesting that some ODC-deficient blastocysts had
more severe defects. A range of concentrations of putrescine
(1 to 100 M) that are known to override a DFMO-induced
cell cycle arrest (35) failed to rescue the growth of ODC-
deficient blastocysts, suggesting that losses in polyamines prior
to this stage compromise the capacity of ODC-deficient ICMs
to expand. Overall, these results demonstrate that the expan-
sion of the ICM is strictly dependent upon ODC.
Loss of ODC results in increased apoptosis of the ICM. The
in vitro growth deficits of ODC-deficient ICMs could be due to
defects in cell cycle progression and/or survival. Polyamines
appear required for chromatin structure and semiconservative
DNA replication but are also required for proper transit
through G2/M (5). To address whether ODC-null blastocysts
had proliferative defects, we immunostained 17 blastocysts
with an antibody that specifically recognizes histone H3 phos-
phorylated at Ser10, which selectively detects cells in mitosis
(1). No striking differences were observed in any of the em-
bryos analyzed, and ODC-deficient blastocysts (n  3) con-
tained similar numbers of mitotic cells as their wild-type litter-
FIG. 3. Zygotic ODC is expressed in blastocysts but is dispensable for blastocyst formation. (A) Representative genotypic analysis of E3.5
embryos from ODC/ breedings. DNA from individual blastocysts was isolated as described in Materials and Methods, and primers were used
to amplify fragments from the wild-type and/or ODC mutant allele in each sample. ODC/ embryos were found at nearly an expected Mendelian
ratio (21%). (B) Phase-contrast photographs of wild-type (left panel) and ODC-null (right panel) blastocysts. ODC-deficient blastocysts appear
morphologically normal. (C) Expression of zygotic ODC, as detected by LacZ staining. An intense signal is observed in both the ICM and the TE
of an ODC-deficient blastocyst. (D) A similar pattern of ODC expression (green) was detected with an ODC-specific antibody in a wild-type
blastocyst. Blastocysts were also stained with propidium iodide (red), which detects DNA. Wt, wild type; Het., heterozygous.
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mates (Fig. 5A). Although we cannot formally exclude an
ODC-dependent proliferative defect after this particular stage
of development, these data suggest that E3.5 ODC-null em-
bryos are not ostensibly impaired in their proliferation.
To address whether ODC-deficient blastocysts had defects
in survival, TUNEL assays were performed on E3.5 blastocysts
isolated from five litters (n  45). We observed evidence of
increased chromosomal DNA breakage associated with apo-
ptosis in about 15% (n  7) of the blastocysts. Although we
could genotype only some of these embryos, ODC-deficient
embryos displayed many fluorescent dots compared to the
small number of TUNEL-positive cells found in their litter-
mates (Fig. 5B). Strikingly, this massive cell death occurs in the
ICM, suggesting that the failure of ODC-deficient ICMs to
expand is due to their intrinsically high rates of apoptosis.
DISCUSSION
ODC is a well-defined target gene for c-Myc and other
oncogenes (6), and ODC activity is necessary and sufficient to
promote transformation (3). Genetic studies of lower organ-
isms such as C. elegans and L. donovani have demonstrated
that ODC plays an essential developmental role, but the cause
of lethality in these ODC-deficient organisms is not resolved
(23, 26). In vertebrates, there is little evidence for a develop-
mental role for ODC other than inhibitor studies. For example,
in vitro depletion of spermine and spermidine by an inhibitor
of S-adenosyl-L-methionine decarboxylase arrests growth be-
fore the eight-cell or morula stage of fertilized murine em-
bryos, whereas DFMO, a potent inhibitor of ODC, arrests
development at the morula-to-blastocyst transition (54). Fur-
thermore, chicken embryos injected with DFMO have marked
reductions in their polyamine levels and fail to develop past
gastrulation (22). Similarly, scheduled administration of DFMO
during pregnancy in mice induces resorption of embryos when
introduced at gestational days 7 and 8 (17). However, these
inhibitors may have other targets, and these experiments fail to
discriminate whether arrest in embryonic development is due
to a lack of maternal ODC or zygotic ODC. Here we have
FIG. 4. ODC-deficient E3.5 blastocysts are compromised in their expansion in vitro. Photographs of the same heterozygous E3.5 blastocyst (a)
at 2 (b) and 3 (c) days in culture and an ODC-deficient blastocyst (d) at 2 (e) and 3 (f) days in culture are shown. A well-developed ICM is evident
in the ODC/ embryo after 3 days, whereas by this time the ICM of the ODC-deficient blastocyst has already completely degenerated. Only the
nondividing trophoblastic giant cells derived from ODC/ blastocysts remained on the plates. ZP, zona pellucida; TG, trophoblastic giant cells.
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FIG. 5. ODC is required for cell survival in the ICM. (A) Comparison of the proliferation index between wild-type (a) and ODC/ (b) E3.5
embryos. Blastocysts were isolated, fixed, and stained with an antibody specific to phosphohistone H3 at Ser10. Two serial sections captured by
confocal imaging of each blastocyst are shown. Mitotic cells are readily detected in embryos from both genotypes. (B) TUNEL analysis of E3.5
blastocysts. The upper panels show phase-contrast photographs of wild-type (c) and ODC/ (d) blastocysts, and the lower panels correspond to
immunodetection of TUNEL labeling (e and f). The wild-type embryo displays minimal apoptosis (e). In contrast, the ODC-deficient embryo
exhibits massive cell death confined to the ICM (f). The arrowheads indicate fluorescent dots corresponding to fragmented DNA. Wt, wild type.
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demonstrated that eliminating ODC function by gene targeting
compromises early mouse embryonic development. ODC-het-
erozygous mice exhibit no visible pathology, at least by 1 year
of age. By contrast, embryos that lack ODC develop normally
to the blastocyst stage and implant but die shortly thereafter,
before the onset of gastrulation.
In spite of the severe phenotype found later, the cleavage
stages, compaction, differentiation of TE, and blastocoel for-
mation can occur independently of zygotic ODC. This is per-
haps not surprising if one posits that maternal stores of ODC
and/or polyamines are present in sufficient quantities in the
embryo until E3.5. In support of this concept, ODC transcripts
are detected in the oocyte by reverse transcription-PCR and
continue to increase in abundance until the morula and blas-
tocyst stages (13). In addition, DFMO treatment arrests devel-
opment in vitro at the morula-to-blastocyst transition (54),
whereas ODC-null embryos develop to the blastocyst stage.
Thus, it appears likely that a maternal component(s) contrib-
utes to the rescue of preimplantation ODC-deficient embryos.
Zygotic ODC expression appears to be crucial when the
decidual reaction takes place in the uterus. This hormonally
regulated process follows the attachment of the hatched blas-
tocyst and involves an increase in the numbers and permeabil-
ity of local capillaries. At the time of implantation, the first
differentiation event within the blastocyst is the proliferation
and invasion of trophoblastic cells through the uterine epithe-
lium. This ensures tight connections between the conceptus
and maternal tissue. Concurrent with this process, the ICM
undergoes rapid proliferation that extends into the blastocoel
cavity to form a structure known as the egg cylinder.
Our work has demonstrated that zygotic ODC is expressed
in both embryonic (ICM) and extraembryonic (TE) compart-
ments (Fig. 3C). ODC-deficient embryos are able to initiate
implantation in vivo, and trophoblast outgrowths appear to
occur normally in culture (Fig. 2). Thus, at face value, these
data would suggest that an extraembryonic defect is not the
cause of the death of ODC-deficient embryos. However, at this
juncture other interpretations of these results are plausible,
and it will be important to perform chimeric studies to evaluate
the developmental fate of ODC-deficient TE. The data are
most consistent with the hypothesis that ODC is critical for the
survival of cells within the ICM compartment, as ODC-defi-
cient ICMs exhibit a marked increase in their apoptotic index
(Fig. 5B). This most likely prevents the expansion of ODC-
deficient ICMs during ex vivo culture, as there appears to be no
defect in the growth of ODC-deficient cells as judged by phos-
phorylation status of H3. However, we cannot exclude the
possibility that there might be later defects in cell growth. The
onset of the ODC-deficient phenotype is stochastic, as some
ODC-deficient embryos can implant whereas others have high
rates of apoptosis at the blastocyst stage. In part, these differ-
ences could reflect the ability of maternal products to maintain
viability of some ODC-deficient embryos. The partial effects of
putrescine rescue in promoting survival of ODC-deficient em-
bryos to E6.5 could similarly be due to differences in damage
suffered by blastocysts and/or to maternal effects. Alterna-
tively, a more trivial interpretation is that the putrescine rescue
actually works but that it is compromised by maternal drinking
behavior. To test this hypothesis, we are currently trying other
ways to supplement the ODC/ pregnant females with pu-
trescine.
A hallmark of the ODC-deficient phenotype is the degen-
eration of the embryo at the early egg cylinder stage. The
knockouts of two other Myc targets, Cul1 and H-ferritin, also
result in embryonic lethal phenotypes, although the lethalities
appear to occur somewhat later (12, 16, 52). The deletion of
Max, the required dimerization partner of Myc, is associated
with defects in the ICM, but this has been attributed previously
to alterations in proliferation rather than survival (46). In
contrast, similar to ODC-deficient embryos, ATR- and Chk-
1-deficient blastocysts have marked defects in their survival.
These observations, along with the null phenotypes of the
oxidative regulators thioredoxin and H-ferritin (16, 27), sug-
gest interesting connections between ODC and the DNA dam-
age pathway. Polyamines stabilize chromatin structure, and
this may account for their ability to prevent DNA damage (48,
49). Furthermore, cells depleted of polyamines are deficient in
their ability to repair X-ray-induced DNA strand breaks, sug-
gesting that they also play a role in stimulating DNA repair
(47). Finally, an emerging concept in the field is that poly-
amines play a proactive role in circumventing DNA damage by
acting as antioxidants (25). Indeed, it has been shown previ-
ously that spermine is an endogenous scavenger of reactive
oxygen species (ROS), which directly induce DNA damage and
chromosomal breakage (21). Paradoxically, the catabolism of
polyamines leads to the production of ROS (30), and this has
been proposed previously to play a physiological role in regu-
lating programmed cell deaths in the blastocyst, where 10% of
the cells of the ICM undergo apoptosis (19). This process
eliminates ICM cells having TE potential, to prevent the for-
mation of TE within the germ layers during gastrulation (41).
By contrast, our data indicate that loss of ODC, and thus de-
pletion of polyamines, leads to massive apoptosis in the ICM.
Based on these observations, we propose two models that
may explain the apoptotic phenotype of ODC deficiency (Fig.
6), and these are not necessarily mutually exclusive. Firstly, im-
balances in polyamine pools may result in inappropriate poly-
amine catabolism and lead to excessive levels of ROS, which
would result in DNA damage and cell death. Secondly, rapid
embryonic growth is always accompanied by an oxidative burst,
and the levels of ROS generated must be detoxified to prevent
cytotoxicity (53). Reductions in intracellular polyamines would
compromise one line of defense, as polyamines directly scav-
enge ROS, and this would place cells of the ICM at risk of
DNA damage and death (Fig. 6).
Taking into account the pleiotropic roles played by poly-
amines in cellular processes, additional alternatives causing
lethality in ODC-deficient embryos cannot be excluded, and
the drastic phenotype observed may be a combination of si-
multaneous defects. In addition to accepted effects on tran-
scription, translation, replication, and growth that are difficult
to reconcile, reductions in polyamines could also affect DNA
methylation. DNA methylation is required for early embryonic
development, and this presumably reflects the demethylation
of DNA at the blastula stage and subsequent de novo methyl-
ation of the entire genome at the time of implantation (29).
There are three DNA methyltransferase genes that play essen-
tial roles during development, Dnmt1, Dnmt3A, and Dnmt3B.
Dnmt1-deficient embryos die between gastrulation and E9.5
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(24), and Dnmt3A/3B double-null embryos die before E11.5
(33), both substantially later than ODC-deficient embryos.
However, the triple Dnmt knockout has not been created, and
it is formally possible that these embryos will display an earlier
lethality. The substrate for DNA methyltransferases is S-ad-
enosylmethionine (AdoMet), which is also a precursor in the
synthesis of the polyamines (50). Conversely, decarboxylated
AdoMet acts as a competitive inhibitor of DNA methyltrans-
ferase (22). Depletions of putrescine and spermidine typically
lead to dramatic increases of decarboxylated AdoMet (18). In
the case of the ODC-deficient embryo, we propose that reduc-
tions in putrescine should result in the accumulation of decar-
boxylated AdoMet and that this may inhibit methylation of the
genome. Further evaluation of the ODC knockout should al-
low us to distinguish between these alternatives.
ACKNOWLEDGMENTS
We are grateful to G. Oliver, C. Kelley, J. Ihle, and M. Donohoe for
advice and stimulating discussions during the course of this work and
to E. White, C. Yang, K. Barnes, and C. Beard for excellent technical
assistance. We thank O. Lagutin and J. Swift for help in isolating
blastocysts, J. Raucci for microinjection, and B. Lorsbach for assis-
tance with the histological laser microdissection. We offer special
thanks to the personnel of SJCRH’s animal resource center and art
department for their efficient and helpful work.
H.P. was a holder of a doctoral fellowship from the FRIA (Belgian
government). This work was supported by grants DK44158 and
CA76379 (to J.L.C.), by Cancer Center Core grant CA-21765, and by
the American Lebanese Syrian Associated Charities (ALSAC) of St.
Jude Children’s Research Hospital.
REFERENCES
1. Ajiro, K., K. Yoda, K. Utsumi, and Y. Nishikawa. 1996. Alteration of cell
cycle-dependent histone phosphorylations by okadaic acid. Induction of mi-
tosis-specific H3 phosphorylation and chromatin condensation in mamma-
lian interphase cells. J. Biol. Chem. 271:13197–13201.
2. Askew, D. S., R. A. Ashmun, B. C. Simmons, and J. L. Cleveland. 1991.
Constitutive c-myc expression in an IL-3-dependent myeloid cell line sup-
presses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915–1922.
3. Auvinen, M., A. Paasinen, L. C. Andersson, and E. Holtta. 1992. Ornithine
decarboxylase activity is critical for cell transformation. Nature 360:355–358.
4. Balasundaram, D., C. W. Tabor, and H. Tabor. 1991. Spermidine or sperm-
ine is essential for the aerobic growth of Saccharomyces cerevisiae. Proc.
Natl. Acad. Sci. USA 88:5872–5876.
5. Balasundaram, D., and A. K. Tyagi. 1991. Polyamine-DNA nexus: structural
ramifications and biological implications. Mol. Cell. Biochem. 100:129–140.
6. Bello-Fernandez, C., and J. L. Cleveland. 1992. c-myc transactivates the
ornithine decarboxylase gene. Curr. Top. Microbiol. Immunol. 182:445–452.
7. Benvenisty, N., A. Leder, A. Kuo, and P. Leder. 1992. An embryonically
expressed gene is a target for c-Myc regulation via the c-Myc-binding se-
quence. Genes Dev. 6:2513–2523.
8. Blackwood, E. M., and R. N. Eisenman. 1991. Max: a helix-loop-helix zipper
protein that forms a sequence-specific DNA-binding complex with Myc.
Science 251:1211–1217.
9. Bruun, L., and G. Houen. 1996. In situ detection of diamine oxidase activity
using enhanced chemiluminescence. Anal. Biochem. 233:130–136.
FIG. 6. Two models of apoptosis caused by loss of ODC. (A) Loss of ODC would be predicted to lead to reductions and an imbalance in
polyamine pools. Polyamine catabolism by polyamine oxidase (PAO) would continue and result in the production of ROS, which result in DNA
damage and cell death. (B) The rapidly dividing cells of the ICM are at risk of damage due to ROS from the oxidative burst, and these are normally
countered by polyamines, which can act as direct scavengers of ROS and/or protect DNA or stimulate DNA repair (21, 47, 48). Loss of ODC would
lead to reductions of polyamine pools and thus place these cells at high risk of death from ROS.
VOL. 21, 2001 ODC IS ESSENTIAL FOR DEVELOPMENT AT IMPLANTATION 6557
10. Celano, P., S. B. Baylin, F. M. Giardiello, B. D. Nelkin, and R. A. Casero.
1988. Effect of polyamine depletion on c-myc expression in human colon
carcinoma cells. J. Biol. Chem. 263:5491–5494.
11. Coppola, J. A., and M. D. Cole. 1986. Constitutive c-myc oncogene expres-
sion blocks mouse erythroleukaemia cell differentiation but not commit-
ment. Nature 320:760–763.
12. Dealy, M. J., K. V. Nguyen, J. Lo, M. Gstaiger, W. Krek, D. Elson, J. Arbeit,
E. T. Kipreos, and R. S. Johnson. 1999. Loss of Cul1 results in early embry-
onic lethality and dysregulation of cyclin E. Nat. Genet. 23:245–248.
13. Domashenko, A. D., K. E. Latham, and K. S. Hatton. 1997. Expression of
myc-family, myc-interacting, and myc-target genes during preimplantation
mouse development. Mol. Reprod. Dev. 47:57–65.
14. Dypbukt, J. M., M. Ankarcrona, M. Burkitt, A. Sjoholm, K. Strom, S.
Orrenius, and P. Nicotera. 1994. Different prooxidant levels stimulate
growth, trigger apoptosis, or produce necrosis of insulin-secreting RINm5F
cells. The role of intracellular polyamines. J. Biol. Chem. 269:30553–30560.
15. Eilers, M., S. Schirm, and J. M. Bishop. 1991. The MYC protein activates
transcription of the alpha-prothymosin gene. EMBO J. 10:133–141.
16. Ferreira, C., D. Bucchini, M. E. Martin, S. Levi, P. Arosio, B. Grandchamp,
and C. Beaumont. 2000. Early embryonic lethality of H ferritin gene deletion
in mice. J. Biol. Chem. 275:3021–3024.
17. Fozard, J. R., M. L. Part, N. J. Prakash, and J. Grove. 1980. Inhibition of
murine embryonic development by alpha-difluoromethylornithine, an irre-
versible inhibitor of ornithine decarboxylase. Eur. J. Pharmacol. 65:379–391.
18. Frostesjo, L., I. Holm, B. Grahn, A. W. Page, T. H. Bestor, and O. Heby.
1997. Interference with DNA methyltransferase activity and genome meth-
ylation during F9 teratocarcinoma stem cell differentiation induced by poly-
amine depletion. J. Biol. Chem. 272:4359–4366.
19. Gramzinski, R. A., R. E. Parchment, and G. B. Pierce. 1990. Evidence linking
programmed cell death in the blastocyst to polyamine oxidation. Differen-
tiation 43:59–65.
20. Grandori, C., J. Mac, F. Siebelt, D. E. Ayer, and R. N. Eisenman. 1996.
Myc-Max heterodimers activate a DEAD box gene and interact with multi-
ple E box-related sites in vivo. EMBO J. 15:4344–4357.
21. Ha, H. C., N. S. Sirisoma, P. Kuppusamy, J. L. Zweier, P. M. Woster, and
R. A. Casero. 1998. The natural polyamine spermine functions directly as a
free radical scavenger. Proc. Natl. Acad. Sci. USA 95:11140–11145.
22. Heby, O., and H. Emanuelsson. 1981. Role of the polyamines in germ cell
differentiation and in early embryonic development. Med. Biol. 59:417–422.
23. Jiang, Y., S. C. Roberts, A. Jardim, N. S. Carter, S. Shih, M. Ariyanayagam,
A. H. Fairlamb, and B. Ullman. 1999. Ornithine decarboxylase gene deletion
mutants of Leishmania donovani. J. Biol. Chem. 274:3781–3788.
24. Li, E., T. H. Bestor, and R. Jaenisch. 1992. Targeted mutation of the DNA
methyltransferase gene results in embryonic lethality. Cell 69:915–926.
25. Lovaas, E. 1997. Antioxidative and metal-chelating effects of polyamines.
Adv. Pharmacol. 38:119–149.
26. MacRae, M., D. L. Kramer, and P. Coffino. 1998. Developmental effect of
polyamine depletion in Caenorhabditis elegans. Biochem. J. 333(Part 2):
309–315.
27. Matsui, M., M. Oshima, H. Oshima, K. Takaku, T. Maruyama, J. Yodoi, and
M. M. Taketo. 1996. Early embryonic lethality caused by targeted disruption
of the mouse thioredoxin gene. Dev. Biol. 178:179–185.
28. Miltenberger, R. J., K. A. Sukow, and P. J. Farnham. 1995. An E-box-
mediated increase in cad transcription at the G1/S-phase boundary is sup-
pressed by inhibitory c-Myc mutants. Mol. Cell. Biol. 15:2527–2535.
29. Monk, M., M. Boubelik, and S. Lehnert. 1987. Temporal and regional
changes in DNA methylation in the embryonic, extraembryonic and germ
cell lineages during mouse embryo development. Development 99:371–382.
30. Morgan, D. M. 1999. Polyamines. An overview. Mol. Biotechnol. 11:229–250.
31. Mountford, P. S., and A. G. Smith. 1995. Internal ribosome entry sites and
dicistronic RNAs in mammalian transgenesis. Trends Genet. 11:179–184.
32. O’Hagan, R. C., M. Ohh, G. David, I. M. de Alboran, F. W. Alt, W. G. Kaelin,
Jr., and R. A. DePinho. 2000. Myc-enhanced expression of Cul1 promotes
ubiquitin-dependent proteolysis and cell cycle progression. Genes Dev. 14:
2185–2191.
33. Okano, M., D. W. Bell, D. A. Haber, and E. Li. 1999. DNA methyltrans-
ferases Dnmt3a and Dnmt3b are essential for de novo methylation and
mammalian development. Cell 99:247–257.
34. Packham, G., and J. L. Cleveland. 1994. Ornithine decarboxylase is a me-
diator of c-Myc-induced apoptosis. Mol. Cell. Biol. 14:5741–5747.
35. Packham, G., C. W. Porter, and J. L. Cleveland. 1996. c-Myc induces apo-
ptosis and cell cycle progression by separable, yet overlapping, pathways.
Oncogene 13:461–469.
36. Parganas, E., D. Wang, D. Stravopodis, D. J. Topham, J. C. Marine, S.
Teglund, E. F. Vanin, S. Bodner, O. R. Colamonici, J. M. van Deursen, G.
Grosveld, and J. N. Ihle. 1998. Jak2 is essential for signaling through a
variety of cytokine receptors. Cell 93:385–395.
37. Park, M. H. 1989. The essential role of hypusine in eukaryotic translation
initiation factor 4D (eIF-4D). Purification of eIF-4D and its precursors and
comparison of their activities. J. Biol. Chem. 264:18531–18535.
38. Pelengaris, S., T. Littlewood, M. Khan, G. Elia, and G. Evan. 1999. Revers-
ible activation of c-Myc in skin: induction of a complex neoplastic phenotype
by a single oncogenic lesion. Mol. Cell 3:565–577.
39. Peralta, S. A., G. Gilliard, L. Megosh, K. George, and T. G. O’Brien. 1998.
Polyamines regulate expression of the neoplastic phenotype in mouse skin.
Cancer Res. 58:1654–1659.
40. Persson, L., E. L. Wallstrom, S. Nasizadeh, C. Dartsch, A. Jeppsson, A.
Wendt, and J. Holmgren. 1998. Regulation of mammalian ornithine decar-
boxylase. Biochem. Soc. Trans. 26:575–579.
41. Pierce, G. B., R. A. Gramzinski, and R. E. Parchment. 1990. Amine oxidases,
programmed cell death, and tissue renewal. Philos. Trans. R. Soc. Lond. B
Biol. Sci. 327:67–74.
42. Pohjanpelto, P., and E. Holtta. 1996. Phosphorylation of Okazaki-like DNA
fragments in mammalian cells and role of polyamines in the processing of
this DNA. EMBO J. 15:1193–1200.
43. Ray, R. M., M. J. Viar, Q. Yuan, and L. R. Johnson. 2000. Polyamine
depletion delays apoptosis of rat intestinal epithelial cells. Am. J. Physiol.
Cell Physiol. 278:C480–C489.
44. Rosenwald, I. B., D. B. Rhoads, L. D. Callanan, K. J. Isselbacher, and E. V.
Schmidt. 1993. Increased expression of eukaryotic translation initiation fac-
tors eIF-4E and eIF-2 alpha in response to growth induction by c-myc. Proc.
Natl. Acad. Sci. USA 90:6175–6178.
45. Schwartz, B., A. Hittelman, L. Daneshvar, H. S. Basu, L. J. Marton, and
B. G. Feuerstein. 1995. A new model for disruption of the ornithine decar-
boxylase gene, SPE1, in Saccharomyces cerevisiae exhibits growth arrest and
genetic instability at the MAT locus. Biochem. J. 312(Part 1):83–90.
46. Shen-Li, H., R. C. O’Hagan, H. Hou, J. W. Horner, H. W. Lee, and R. A.
DePinho. 2000. Essential role for Max in early embryonic growth and devel-
opment. Genes Dev. 14:17–22.
47. Snyder, R. D. 1989. Inhibition of X-ray-induced DNA strand break repair in
polyamine-depleted HeLa cells. Int. J. Radiat. Biol. 55:773–782.
48. Snyder, R. D. 1989. Polyamine depletion is associated with altered chromatin
structure in HeLa cells. Biochem. J. 260:697–704.
49. Snyder, R. D., and P. J. Lachmann. 1989. Hyperthermia, polyamine deple-
tion, and inhibition of X-ray-induced DNA strand break repair. Radiat. Res.
120:121–128.
50. Tabor, C. W., and H. Tabor. 1984. Polyamines. Annu. Rev. Biochem. 53:
749–790.
51. van Deursen, J., J. Boer, L. Kasper, and G. Grosveld. 1996. G2 arrest and
impaired nucleocytoplasmic transport in mouse embryos lacking the proto-
oncogene CAN/Nup214. EMBO J. 15:5574–5583.
52. Wang, Y., S. Penfold, X. Tang, N. Hattori, P. Riley, J. W. Harper, J. C. Cross,
and M. Tyers. 1999. Deletion of the Cul1 gene in mice causes arrest in early
embryogenesis and accumulation of cyclin E. Curr. Biol. 9:1191–1194.
53. Winn, L. M., and P. G. Wells. 1995. Phenytoin-initiated DNA oxidation in
murine embryo culture, and embryo protection by the antioxidative enzymes
superoxide dismutase and catalase: evidence for reactive oxygen species-
mediated DNA oxidation in the molecular mechanism of phenytoin terato-
genicity. Mol. Pharmacol. 48:112–120.
54. Zwierzchowski, L., M. Czlonkowska, and A. Guszkiewicz. 1986. Effect of
polyamine limitation on DNA synthesis and development of mouse preim-
plantation embryos in vitro. J. Reprod. Fertil. 76:115–121.
6558 PENDEVILLE ET AL. MOL. CELL. BIOL.
